Celon Pharma S.A. submitted an application for a construction permit for its Research and Development Centre

On 26 July this year, the Company submitted an application to build a Research and Development Centre – a modern facility which will integrate i.a. innovative projects of the Company.  The total cost of the investment amounts to approx. PLN 80 million.
The construction of Research and Development Centre will be financed by the proceeds raised from the initial public offering of the Company’s shares as well as from the Innovative Economy Programme. Research and Development Centre will be constructed in immediate proximity to the Company's Medicinal Product Production and Packaging Plant in Kazuń Nowy [Zakład Wytwarzania i Konfekcjonowania Produktów Leczniczych Spółki].
Maciej Wieczorek, PhD, President of the Board of Celon Pharma S.A.: We pursue a strategy which assumes that development and commercialisation of innovative therapies will constitute a key element of our business activity in the following years. We act in accordance with the adopted schedule. At the present moment, we submitted an application for the construction along with documentation, and we are completing an executive design. These assumptions allow for full streamlining and optimisation of the R&D processes of the company to be conducted at one location by 2019.The new Celon Pharma S.A. Research and Development Centre will be equipped with a number of specialised laboratories. It is anticipated that the Centre will employ about 150 scientists.